Clinical Trial Update: Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Velcaflagida for relapsed or refractory acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Velcaflagida

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED